Archimedes Tech Spac Partner
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 57.85%
$664M
$25.5 Million
0.0% of portfolio
4,815,563
Q3 2025
Added 37.81%
$0
$52.5 Million
0.0% of portfolio
1,147,771
Q3 2025
Added 23.32%
-
$0
0.0% of portfolio
-
Q3 2025
Added 116.32%
-
$0
0.0% of portfolio
-
Q3 2025
Added 3.14%
$2.76B
$28.3 Million
0.0% of portfolio
172,228
Q3 2025
Reduced 52.22%
$0
$0
0.0% of portfolio
1
Q3 2025
New
$0
$32.2 Million
0.0% of portfolio
2,903,353
Q3 2025
Added 6.59%
Inovio Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2025
Added 95.78%
$5.94B
$67 Million
0.0% of portfolio
1,434,642
Q3 2025
Added 36.5%
Seanergy Maritime Hldgs Corp
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.8%
$2.91B
$139,000
0.0% of portfolio
315,968
Q3 2025
Reduced 5.88%
$1.09B
$59.8 Million
0.0% of portfolio
3,728,268
Q3 2025
Added 184.29%
-
$0
0.0% of portfolio
-
Q3 2025
New
$259M
$3.52 Million
0.0% of portfolio
769,283
Q3 2025
Reduced 18.67%
Neumora Therapeutics Inc.
-
$0
0.0% of portfolio
-
Q3 2025
Added 20.18%
Helius Med Technologies Inc
-
$0
0.0% of portfolio
-
Q3 2025
New
$1.57B
$14.8 Million
0.0% of portfolio
194,510
Q3 2025
Reduced 14.19%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 98.4%
Bright Scholar Ed Hldgs LTD
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 10.34%
$1.9B
$30.6 Million
0.0% of portfolio
1,883,298
Q3 2025
Added 59.79%
$5.7B
$59.3 Million
0.0% of portfolio
1,636,187
Q3 2025
Reduced 8.78%
$0
$6.35 Million
0.0% of portfolio
93,495
Q3 2025
Reduced 16.33%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 98.67%
-
$0
0.0% of portfolio
-
Q3 2025
New
$55.5M
$72,000
0.0% of portfolio
49,011
Q3 2025
Added 156.86%
$1.06B
$14.2 Million
0.0% of portfolio
539,182
Q3 2025
Reduced 13.38%
Dragonfly Energy Holdings CO
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 21.23%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 5.5%
$0
$12.5 Million
0.0% of portfolio
279,843
Q3 2025
Added 4.99%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 56.12%
$416M
$9.04 Million
0.0% of portfolio
312,004
Q3 2025
Reduced 23.59%
$0
$1.28 Million
0.0% of portfolio
16,817
Q3 2025
Reduced 65.69%
$33.4M
$52,000
0.0% of portfolio
7,924
Q3 2025
Added 37.07%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 43.8%
$3.69B
$30.1 Million
0.0% of portfolio
691,512
Q3 2025
Added 55.09%
$0
$169,000
0.0% of portfolio
3,751
Q2 2025
Added 375,000.0%
$25.9M
$434,000
0.0% of portfolio
310,291
Q3 2025
Added 41.44%
-
$0
0.0% of portfolio
-
Q3 2025
Added 174.38%
$0
$65.3 Million
0.0% of portfolio
1,265,802
Q3 2025
Reduced 0.07%
$716M
$6.95 Million
0.0% of portfolio
113,497
Q3 2025
Reduced 2.44%
$0
$4.11 Million
0.0% of portfolio
823,786
Q3 2025
Added 3.98%
J P Morgan Exchange Traded F
-
$0
0.0% of portfolio
-
Q3 2025
Added 12,725.71%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 87.5%
-
$0
0.0% of portfolio
-
Q3 2025
Added 56.18%
-
$0
0.0% of portfolio
-
Q3 2025
Added 28.56%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.69%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 35.86%
$1.35B
$55.5 Million
0.0% of portfolio
1,348,160
Q3 2025
Added 40.33%
-
$0
0.0% of portfolio
-
Q1 2025
New